Table 2.
Clinical presentations in patients with COVID-19
| Total | Under 65 | Over 65 | t or χ2 or U | P value | |
|---|---|---|---|---|---|
| Symptoms and signs (n, % or mean ± S.D.) | n = 91 | n = 64 | n = 27 | ||
| Fever | 78 | 55 | 23 | 0 | 1.0 |
| Maximum body temperature during the course of the disease | 38.52 ± 0.57 | 38.51 ± 0.58 | 38.54 ± 0.56 | − 0.242 | 0.81 |
| < 37.3 °C | 13 | 9 | 4 | 0 | 1.0 |
| 37.3–38 °C | 17 | 13 | 4 | 0.378 | 0.54 |
| 38.1–39 °C | 49 | 35 | 14 | 0.061 | 0.80 |
| > 39 °C | 12 | 7 | 5 | 0.406 | 0.52 |
| Duration of fever | 8.94 ± 4.13 | 8.82 ± 3.38 | 9.22 ± 5.62 | − 0.317 | 0.75 |
| Cough | 59 | 40 | 19 | 0.516 | 0.47 |
| Expectoration | 30 | 15 | 15 | 8.864 | 0.003* |
| Fatigue | 24 | 17 | 7 | 0.004 | 0.95 |
| Dyspnea | 24 | 10 | 14 | 12.834 | < 0.001* |
| Myalgia | 18 | 17 | 1 | 6.253 | 0.012* |
| Pharyngalgia | 16 | 14 | 2 | 1.836 | 0.18 |
| Nausea | 11 | 6 | 5 | 0.757 | 0.38 |
| Chills | 10 | 9 | 1 | 1.159 | 0.28 |
| Nasal congestion | 10 | 8 | 2 | 0.117 | 0.73 |
| Abdominal pain | 3 | 3 | 0 | 0.251 | 0.62 |
| Respiratory rate | 20.0(20.0–21.0) | 20 (19–20.75) | 20.0 (20.0–22.0) | − 2.246 | 0.02* |
| Heart rate | 82 (80–90) | 82 (80–90) | 82 (75–90) | − 0.515 | 0.61 |
| Mean arterial pressure (mmHg) | 90.49 ± 13.65 | 89.65 ± 14.07 | 92.49 ± 12.64 | − 0.906 | 0.37 |
| Blood oxygen saturation,% median(range) | 97.60 (95.25–99.00) | 97.80 (95.30–99.00) | 97.30 (94.60–98.30) | − 0.961 | 0.34 |
Data were shown as mean ± standard deviation, median (Q1, Q3), or n (%). P values indicate differences between the elderly group and the young/middle-aged group
COVID-19 Coronavirus disease 2019.
*P < 0.05 was considered statistically significant